Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

Core Insights - Sight Sciences, Inc. announced that two Medicare Administrative Contractors (MACs), Novitas Solutions and First Coast Service Options, have established pricing for CPT code 0563T, which pertains to the TearCare® System for treating meibomian gland dysfunction [1][2][3] - The local fee schedule for CPT code 0563T will be effective for services on or after January 1, 2025, and will be available for eyecare providers in the respective jurisdictions [2][5] - The regions covered by Novitas and First Coast represent approximately 30% of total Medicare fee-for-service covered lives, amounting to an estimated 10.4 million covered lives [3][4] Company Developments - The CEO of Sight Sciences expressed gratitude for the established pricing, emphasizing the importance of access to the TearCare treatment for Medicare beneficiaries [1][5] - The company has launched the Sight Access Portal to assist providers with patient benefit verifications, prior authorizations, and reimbursement inquiries related to the TearCare System and other surgical systems [5][6] - Sight Sciences plans to provide updated revenue and adjusted operating expenses guidance during its third quarter 2025 earnings call [5] Industry Context - The TearCare® System is designed to address evaporative dry eye disease caused by meibomian gland disease, which is a prevalent condition affecting many patients [6][7] - The company focuses on developing innovative, minimally invasive technologies to improve patient care and transform treatment paradigms in eyecare [6][7]